Abnormalities in circadian blood pressure variability and endothelial function: Pragmatic markers for adverse cardiometabolic profiles in asymptomatic obese adults

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Gupta, Alok K ^a   Cornelissen, Germaine ^c   Greenway, Frank L ^a   Dhoopati, Vijay ^b   Halberg, Franz ^c   Johnson, William D ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b Amarika Family Medicine   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ADULT; ADVERSE OUTCOME; AMBULATORY MONITORING; ANTHROPOMETRIC PARAMETERS; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; BODY MASS; BODY WEIGHT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; OBESITY; PULSE PRESSURE; RISK ASSESSMENT; SCREENING; ULTRASOUND; VASCULAR ENDOTHELIUM; WAIST CIRCUMFERENCE; WEIGHT REDUCTION; AGED; BLOOD PRESSURE; COMORBIDITY; HYPERGLYCEMIA; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RISK FACTOR;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; CIRCADIAN RHYTHM; COMORBIDITY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERGLYCEMIA; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 77956943194     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-58     Document Type: Article

References (44)

1. Eckel RH, York DA, Rossner S, Hubbard V, Caterson I, St Jeor ST, Hayman LL, Mullis RM, Blair SN, . American Heart Association Prevention Conference VII: obesity, a worldwide epidemic related to heart disease and stroke: executive summary. Circulation 2004, 110:2968-2975. 10.1161/01.CIR.0000140086.88453.9A, 15520336, American Heart Association.
2. World Health Organization Obesity: Preventing and managing the global epidemic. [WHO Technical report series No. 894] 2000, Geneva. World Health Organization, World Health Organization.
3. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-e171. 10.1161/CIRCULATIONAHA.106.179918, 17194875.
4. World Health Organization Web site Cardiovascular disease: prevention and control 2003, World Health Organization Web site., http://www.who.int/dietphysicalactivity/publications/facts/cvd/en/
5. Stokes J, Kannel WB, Wolf PA, Cupples LA, D'Agostino RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham Study. Circulation 1987, 75(6 Pt 2):V65-73.
6. Kannel WB, D'Agostino RB, Sullivan L, Wilson PW. Concept and usefulness of cardiovascular risk profiles. Am Heart J 2004, 148(1):16-26. 10.1016/j.ahj.2003.10.022, 15215787.
7. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Type 2 diabetes as a 'coronary heart disease equivalent': an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005, 28:2901-2907. 10.2337/diacare.28.12.2901, 16306552.
8. Whiteley L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care 2005, 28:1588-1593. 10.2337/diacare.28.7.1588, 15983305.
9. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. 10.1056/NEJM199309303291401, 8366922, The Diabetes Control and Complications Trial Research Group.
10. Nielson C, Lange T, Hadjokas N. Blood glucose and coronary artery disease in nondiabetic patients. Diabetes Care 2006, 29:998-1001. 10.2337/dc05-1902, 16644627.
11. Schnell O, Standl E. Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocr Pract 2006, 12(Suppl 1):16-19.
12. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE. Risk of cardiovascular and all cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007, 116:151-157. 10.1161/CIRCULATIONAHA.106.685628, 17576864.
13. Diamantopoulos EJ, Andreadis EA, Tsourous GI, Katsanou PM, Georgiopoulos DX, Nestora KC, Raptis SA. Early vascular lesions in subjects with metabolic syndrome and prediabetes. Int Angiol 2006, 25:179-183.
14. Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O'Donnell CJ. Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham offspring study. Diabetes Care 2002, 25:1313-1319. 10.2337/diacare.25.8.1313, 12145227.
15. Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F. Prediabetes is Associated with Abnormal Circadian Blood Pressure Variability. J Hum Hypertens 2008, 22(9):627-33. 10.1038/jhh.2008.32, 2573901, 18480832.
16. Gupta AK, Greenway FL, Cornelissen G, Pan W, Halberg F, Gupta AK, Johnson WD. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm (Lond) 2010, 7:36. 10.1186/1476-9255-7-36, 2920244, 20659335.
17. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RH. Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA 1978, 240:1607-1610. 10.1001/jama.240.15.1607, 691146.
18. Kashyap ML. Cholesterol and atherosclerosis: a contemporary perspective. Ann Acad Med Singapore 1997, 26(4):517-23.
19. Kim SH, Reaven GM. The metabolic syndrome: one step forward, two steps back. Diab Vasc Dis Res 2004, 1:68-75. 10.3132/dvdr.2004.010, 16304726.
20. Reaven GM. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med 2005, 47:201-210.
21. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004, 109:42-46. 10.1161/01.CIR.0000108926.04022.0C, 14676144.
22. Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993, 119:1187-1197.
23. Michos ED, Vasamreddy CR, Becker DM, Yanek LR, Moy TF, Fishman EK, Becker LC, Blumenthal RS. Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis. Am Heart J 2005, 150(6):1276-81. 10.1016/j.ahj.2005.02.037, 16338271.
24. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999, 353:89-92. 10.1016/S0140-6736(98)10279-9, 10023892.
25. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, Wolf PA. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006, 37:345-350. 10.1161/01.STR.0000199613.38911.b2, 16397184.
26. Standards of medical care in diabetes--2007 American Diabetes Association. Diabetes Care 2007, 30(Suppl 1):S4-S41. Standards of medical care in diabetes--2007.
27. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, . National Heart and Blood Institute Joint National Committee on prevention, detection, evalution, and treatment of high blood pressure; National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003, 289:2560-2572. 10.1001/jama.289.19.2560, 12748199, National Heart and Blood Institute Joint National Committee on prevention, detection, evalution, and treatment of high blood pressure; National High Blood Pressure Education Program Coordinating Committee.
28. Otsuka K, Cornélissen G, Halberg F, Oehlerts G. Excessive circadian amplitude of blood pressure increases risk of ischaemic stroke and nephropathy. J Med Eng Technol 1997, 21(1):23-30. 10.3109/03091909709030299, 9080358.
29. Halberg F, Cornélissen G, Katinas G, Tvildiani L, Gigolashvili M, Janashia K, Toba T, Revilla M, Regal P, Sothern RB, Wendt HW, Wang ZR, Zeman M, Jozsa R, Singh RB, Mitsutake G, Chibisov SM, Lee J, Holley D, Holte JE, Sonkowsky RP, Schwartzkopff O, Delmore P, Otsuka K, Bakken EE, Czaplicki J, . International BIOCOS Group Chronobiology's progress: season's appreciations 2004-2005. Time, frequency, phase, variable, individual, age- and site-specific chronomics. J Appl Biomed 2006, 4:1-38. International BIOCOS Group.
30. Corrado E, Rizzo M, Coppola G, Muratori I, Carella M, Novo S. Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis 2008, 19(3):139-44. 10.1097/MCA.0b013e3282f3fbde, 18418229.
31. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity (Silver Spring) 2007, 15(1):216-24. 10.1038/oby.2007.505, 17228050.
32. Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond) 2009, 33(2):239-48. 10.1038/ijo.2008.252, 19050677.
33. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB, O'Donnell CJ. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116(1):39-48. 10.1161/CIRCULATIONAHA.106.675355, 17576866.
34. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005, 96(9):939-49. Review, 10.1161/01.RES.0000163635.62927.34, 15890981.
35. Inadera H. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 2008, 5(5):248-62. 2528071, 18773088.
36. Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW, Chittleborough CR, Gill TK, Ruffin RE. Independent Association of HbA (1c) and Incident Cardiovascular Disease in People Without Diabetes. Obesity (Silver Spring). Obesity (Silver Spring) 2009, 17(3):559-63. 10.1038/oby.2008.592, 19131940.
37. Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study. Eur J Cardiovasc Prev Rehabil 2008, 15(5):594-8. 10.1097/HJR.0b013e328308bb8b, 18753952.
38. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH, Howard BV, Assaf AR, Prentice R, . Women's Health Initiative Research Group Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005, 165(5):500-8. 10.1001/archinte.165.5.500, 15767524, Women's Health Initiative Research Group.
39. Kim SY, De Vera MA, Choi HK. Gout and mortality. Clin Exp Rheumatol 2008, 26(5 Suppl 5):S115-9.
40. Gupta AK, McGlone M, Greenway FL, Johnson WD. Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res 2010, 33(9):905-10. 10.1038/hr.2010.91, 20535113.
41. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110(10):1245-50. 10.1161/01.CIR.0000140677.20606.0E, 15326067.
42. Takeda N, Maemura K. Circadian clock and vascular disease. Hypertens Res 2010, 33(7):645-51. 10.1038/hr.2010.68, 20448639.
43. White WB. How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension?. Blood Press Monit 1999, 4(Suppl 2):S17-S21. (review).
44. Felício JS, de Souza AC, Kohlmann N, Kohlmann O, Ribeiro AB, Zanella MT. Nocturnal blood pressure fall as predictor of diabetic nephropathy in hypertensive patients with type 2 diabetes. Cardiovasc Diabetol 2010, 13(9):36.